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H I G H L I G H T S
• 3D bioprinting allows controlled deposition of cells in space at micrometric scale.
• ESCs and iPSCs can be used to generate 3D bioprinted models of several human organs.
• We discuss challenges and opportunities of bioprinting human brain cells.
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A B S T R A C T
Three-dimensional (3D) printing of biological material, or 3D bioprinting, is a rapidly expanding field with
interesting applications in tissue engineering and regenerative medicine. Bioprinters use cells and biocompatible
materials as an ink (bioink) to build 3D structures representative of organs and tissues, in a controlled manner
and with micrometric resolution. Human embryonic (hESCs) and induced (hiPSCs) pluripotent stem cells are
ideally able to provide all cell types found in the human body. A limited, but growing, number of recent reports
suggest that cells derived by differentiation of hESCs and hiPSCs can be used as building blocks in bioprinted
human 3D models, reproducing the cellular variety and cytoarchitecture of real tissues. In this review we will
illustrate these examples, which include hepatic, cardiac, vascular, corneal and cartilage tissues, and discuss




The term ‘biofabrication’ refers to ‘a process that results in a defined
product with biological function’ (Groll et al., 2016). This general de-
finition encompasses the technologies that use cells as building blocks
and materials as cement, to generate three-dimensional (3D) constructs.
In this way, biofabrication provides the possibility to combine cells in a
controlled way, to build structures that closely mimic natural tissues.
3D bioprinting, which is included among the methods of biofabrication,
allows the assembly of artificial tissues by printing a suspension of cells
or cell aggregates in a natural or synthetic extracellular matrix. Some
methods use an ink, made of a combination of biocompatible non-living
materials and living material (bioink). The bioink is deposited in 3D
space using computer-numerically-controlled (CNC) machines to re-
produce tissue architecture at the micrometric scale.
Three main techniques based on the deposition of a cellularized
bioink have been developed so far: inkjet, laser-assisted and extrusion-
based (Hölzl et al., 2016). Inkjet bioprinting, one of the first approaches
to produce 3D biological constructs by printing through a nozzle
(Nishiyama et al., 2009), uses inkjet cartridges and piezoelectric ac-
tuators, which exploit electricity for precise movement control, or
thermal microheaters, based on temperature, to eject micrometric
droplets of bioink (Fig. 1A). Inkjet bioprinters are simple to use but the
choice of the bioink is limited by its rheological properties, namely
density, viscosity and surface tension. Only bioinks with low viscosity
can be used to avoid clogging issues. This strongly limits the possibility
to tune cell density and matrices formulation, making inkjet bioprinting
unsuitable for most applications. This limitation is circumvented in
deposition approaches based on a laser, which represent nozzle-free
bioprinting methods. Laser-assisted bioprinting (LaBP) (Koch et al.,
2013) uses a planar donor slide loaded with the bioink and a laser-pen
(Fig. 1B). The donor slide (mounted upside-down) is coated with a thin
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laser absorbing layer and a thicker layer containing cells and bioma-
terial (bioink) to be printed. A vapor bubble is formed upon laser fo-
cusing on the absorbing layer, triggering the downwards expulsion of
micrometric droplets from the substrate. Bioink droplets are thus de-
posited on an underlying collector substrate layer-by-layer, allowing
the formation of arbitrary patterns and stratified 3D structures. High
resolution and freedom in the bioink formulation are major points of
strength of LaBP, while time-consuming slide preparation, high costs
and low accessibility to the general user are regarded as important
limitations. Extrusion bioprinting overcomes some of the limitations of
the aforementioned deposition techniques and has become the most
popular bioprinting approach (Costantini et al., 2018). These bio-
printers extrude the bioink out of nozzles using pneumatic or piston-
driven actuators, depositing cellularized filaments with micrometric
resolution (Fig. 1C). Microfiber deposition is particularly suitable to
mimic tissues with elongated architectures or cylindrical symmetry, like
blood vessels, hepatic lobules, muscle fibers or neuronal fascicles. Dif-
ferent techniques have been developed for inducing the transition of the
bioink from sol (non-gelled precursor, with liquid behavior) to gel
(solid-like behavior) during extrusion bioprinting. One possibility is
represented by direct printing into a coagulation bath, containing a
crosslinking solution that triggers bioink gelation. For instance, bioinks
containing the polysaccharide alginate, derived from the cell walls of
brown algae, rapidly gel by ionic crosslinking upon extrusion in a so-
lution of calcium chloride (Andersen et al., 2015). A recent evolution of
extrusion-based bioprinting consists in the implementation of the ex-
truding nozzle with microfluidic devices. In co-axial wet-spinning 3D
bioprinting, the bioink and the coagulation solution are extruded si-
multaneously. As a result, sol-gel transition occurs at the tip of the
printing head, dispensing the hydrogel with rapid and precise control
on its spatial positioning (Colosi et al., 2017; Costantini et al., 2018).
Other biofabrication techniques allow controlled generation of cel-
lularized 3D constructs without relying on layer-by-layer deposition of
biomaterials. The Kenzan method is a scaffold-free bioassembling pro-
cedure based on the initial formation of cell aggregates or spheroids in
conventional cultures. During this process, cells spontaneously produce
extracellular matrix. Preformed spheroids, in the absence of any bioink,
are then laced by a robotic platform into arrayed steel microneedles
(Fig. 1D), named kenzan (“sword mountain”) from the device used in
the Japanese art of flower arrangement ikebana. The kenzan provide
temporary support for further cultivation, allowing fusion of spheroids
into larger cellular aggregates (Moldovan et al., 2017a). Stereo-
lithography-based bioprinting systems use light to induce polymeriza-
tion of light-sensitive materials. This is achieved by exploiting the re-
activity of photoinitiators, which trigger the formation of polymer
chains from monomeric materials upon ultraviolet (UV) or visible light
exposure (Mondschein et al., 2017) (Fig. 1E). This method avoids ne-
gative effects of nozzle-based bioprinting in terms of shear pressure,
velocity and high resolution. However, exposure to ultraviolet and
near-ultraviolet light may potentially be cytotoxic for the cells, indu-
cing DNA damages, and the choice of photocrosslinkable biomaterials is
limited.
A number of possible biomedical applications have been proposed
for 3D bioprinting, ranging from regenerative medicine to disease
modeling. The ability to produce a three-dimensional biological con-
struct that mimics a tissue is clearly of interest for repairing, or re-
generating, the same tissue in a patient. Moreover, an artificial tissue
made of cells carrying pathogenic mutations might be used to study
disease onset and progression and for pharmacokinetic studies in vitro
(Guillemot et al., 2010). For both basic biology studies and biomedical
applications of 3D bioprinting, two crucial requirements must be met:
a) cells inside the printed construct must be representative of the cell
types in the real tissue; b) the cytoarchitecture of the artificial tissue
must recapitulate at best the physiological organization. Comparative
overview of the literature shows that common bioprinting technologies
differ in terms of throughput, cell viability, resolution, speed and costs,
among other features (Knowlton et al., 2015; Moroni et al., 2018). It
should be noted that there is always a trade between resolution, com-
patibility with cell deposition, cell viability as well as mechanical sta-
bility and no one of the existing 3D bioprinting methods is able to
provide all advantages (Ionov, 2018). This is a recent technology and
many gaps must be filled before the above-mentioned requirements can
be fulfilled. An important limitation is the quality of the “building
blocks”, i.e. the cells. Some specialized cell types can be obtained di-
rectly from an individual if they reside in an accessible tissue, such as
blood or skin. Other kinds of cells can be derived from adult stem or
progenitor cells, such as mesenchymal stem cells or satellite (muscle
stem) cells, which have a limited differentiation potential. However,
biofabrication methods would convey their maximum potential only if
a cell source is found that: a) can provide all cells of interest, including
non-accessible cells such as neurons or cardiomyocytes; b) can be ob-
tained in scalable amounts; c) can be derived directly from a patient,
thus carrying the same genetic background.
In this review we will discuss the possibility of producing in vitro
constructs by 3D bioprinting, using human pluripotent stem cells as
biological material. We will present relevant examples in recent lit-
erature, where different bioprinting methods have been used to gen-
erate a range of 3D constructs, with the aim of reproducing human
tissues.
1.2. Human pluripotent stem cells: from conventional 2D to novel 3D
cultures
Human Pluripotent Stem Cells (hPSCs) include Embryonic Stem
Cells (hESCs) and induced Pluripotent Stem Cells (hiPSCs). These cells
fulfill all the above-mentioned requirements for the “building block”:
they can be virtually converted into any cell type (pluripotency) and are
endowed with unlimited self-renewal capacity (stemness). Induction of
Fig. 1. 3D bioprinting strategies. The figure is a schematic representation of the methods used so far for bioprinting undifferentiated hPSCs or differentiated cells
derived from hPSCs. (A) Inkjet bioprinting. (B) Laser-assisted bioprinting. (C) Extrusion-based bioprinting. (D) Kenzan method. (E) Stereolithography-based bio-
printing. See text for detailed description of each method.
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pluripotency in somatic cells by defined factors has been first described
in mouse (Takahashi and Yamanaka, 2006) and then in human
(Takahashi et al., 2007; Yu et al., 2007). While hESCs can only be de-
rived by destruction of a blastocyst stage embryo, these seminal studies
provided the possibility of generating hiPSCs from adult cells (e.g. skin
or blood) by a “reprogramming” process. Moreover, hiPSCs with pa-
thogenic mutations can be obtained from patients and the genetic de-
fect can be introduced (or corrected) by genome editing (Kiskinis et al.,
2014). The possibility to obtain hiPSCs carrying pathogenic mutations
and their plurilineage differentiation potential make this cell system a
powerful tool for advancing our knowledge on the fundamental me-
chanisms underlying human tissue homeostasis and disease, for drug
screening and for regenerative medicine. A great drive in the generation
of hiPSCs representative of human diseases has marked the past decade.
As biomedical applications require hiPSC differentiation into disease-
relevant cell types, development of proper differentiation methods is
mandatory to fully exploit their potential. However, generating the full
variety of sub-types of cells that make human organs and tissues re-
mains a challenge.
Moving from conventional 2D cultures to 3D is regarded as a pro-
mise of significant improvement towards the production of more phy-
siological in vitro models of human development and disease. The need
for more realistic models is particularly relevant for neurological dis-
eases (Centeno et al., 2018). Inter-species differences and human-spe-
cific features of brain development are not always recapitulated in
animal models. Moreover, access to human brain tissue is limited and
neurons cannot be easily cultured and expanded in vitro. Despite hPSCs
provide the opportunity of generating human neurons in vitro, con-
ventional 2D cultures of hPSC-derived neurons have several limitations:
they do not mimic the complex brain tissue organization, cell-cell in-
teractions are limited to side-by-side contacts, dynamics of nutrients
and oxygen diffusion and waste removal are lacking. Notably, in the
few cases in which 2D and 3D hiPSC-based models have been com-
pared, 3D models have better recapitulated Alzheimer’s disease phe-
notypes (Zhang et al., 2014; Lee et al., 2016). An improvement over
conventional 2D models was also demonstrated for neurodevelop-
mental disorders. For instance, hiPSC-derived 3D brain organoids have
been successfully used to model microcephaly (Lancaster et al., 2013),
Miller-Dieker Syndrome (Iefremova et al., 2017), Lissencephaly
(Bershteyn et al., 2017), Timothy syndrome (Birey et al., 2017) and to
study the effects of Zika virus infection on human neural development
(Qian et al., 2016; Dang et al., 2016; Cugola et al., 2016; Garcez et al.,
2016). Human brain organoids are built by self-organization of differ-
entiating hiPSCs along the neural lineage. Both the variety of the cell
types and the main organization of the brain are recapitulated, to some
extent, in a self-assembled brain organoid (Kelava and Lancaster,
2016). In addition to the self-assembled whole-brain organoids de-
scribed by Lancaster et al. (Lancaster et al., 2013), other brain organoid
models, based on the use of patterning cues to direct the formation of
specific brain regions, have been established (recently reviewed in
Arlotta and Paşca, 2019).
At present, unfortunately, reproducibility is regarded as a major
issue in the field. Lab-to-lab (and sometimes individual-to-individual)
variation in methodologies, cell lines, manipulation and plastics mate-
rial, have been all recognized as significant sources of variability
(Jabaudon and Lancaster, 2018). Moreover, the process of self-assembly
often produces significant variability in quality and brain regions of
different batches of organoids (Lancaster and Knoblich, 2014). Such
“batch syndrome” (Kelava and Lancaster, 2016) can be partially ad-
dressed by guiding the cell self-organization with fiber microfilaments,
used as floating scaffolds to produce microfilament-engineered cerebral
organoids (enCORs) (Lancaster et al., 2017). More recently, the Arlotta
laboratory has shown that moving from self-patterned organoids
(Quadrato et al., 2017) to models involving the use of exogenous factors
to influence patterning (Velasco et al., 2019) greatly improved re-
producibility by reducing variability issues in terms of cell type
composition.
1.3. Challenges in 3D bioprinting human PSCs
Bioprinting would represent a possible alternative to guide the as-
sembling process of a 3D model, as it would allow combining cells and
matrices into a single construct with a defined pattern at the micro-
metric scale. Application of 3D bioprinting to hPSCs is a field at its
infancy. Only recently, advancements in biofabrication techniques have
opened the possibility to apply these methodologies to hPSCs. Despite
the enormous potential of hiPSCs for disease modeling and regenerative
medicine, and despite the boost that biofabrication methods might
provide to the cell system, only a handful of recent reports describe
bioprinted human 3D constructs based on hPSCs. This gap is mainly due
to some peculiar characteristics of hPSCs, which make bioprinting
challenging for this kind of cells. First, hPSCs show poor survival in
culture as single cells, and single cell dissociation is a necessary step in
most bioprinting procedures. Second, hPSCs are highly responsive to
environmental cues, due to their intrinsic nature of embryonic-like cells
able to respond to developmental signals. Third, hPSCs tend to form
clusters, or colonies, due to their epithelial character. This propensity
must be taken into consideration when nozzle-based bioprinting
methods are used.
Recent reports showed that undifferentiated hPSCs can be bio-
printed using extrusion (Faulkner-Jones et al., 2015; Reid et al., 2016;
Gu et al., 2017; Nguyen et al., 2017) and laser (Koch et al., 2018).
Following the printing procedure, maintenance of pluripotency -i.e. the
ability to differentiate into ideally any cell type- is a crucial point that
must be accurately evaluated. In some cases, directed differentiation of
hPSCs within the printed construct was demonstrated, namely along
cartilage (Nguyen et al., 2017), cardiac (Koch et al., 2018) and neural
(Gu et al., 2017) lineages. These procedures, in which hPSCs are first
printed as an undifferentiated population and then induced to differ-
entiate either to multiple lineages or into a specific cell type of interest,
are defined here as “post-printing differentiation” (Fig. 2A). The re-
versal approach, consisting of printing lineage-committed cells, pre-
viously obtained by hPSCs differentiation, is defined here as “pre-
printing differentiation” (Fig. 2B). Examples of this latter approach
include hepatocytes (Faulkner-Jones et al., 2015; Ma et al., 2016; Yu
et al., 2019), cardiomyocytes (Ong et al., 2017a; Ong et al., 2017b; Yu
et al., 2019), endothelial and smooth muscle cells (to obtain vascular
tissue; Moldovan et al., 2017b) and limbal epithelial stem cell (to obtain
corneal tissue; Sorkio et al., 2018), derived from hPSCs by conventional
differentiation and then used as biological material for bioprinting.
In the following sections we will describe relevant examples of both
post-printing differentiation and pre-printing differentiation in recent
literature (summarized in Table 1), highlighting main advantages and
caveats.
1.4. Bioprinting undifferentiated hPSCs and post-printing differentiation
To the best of our knowledge, the first report of hPSCs used in
biofabrication is the work by Faulkner-Jones et al. (2013). These au-
thors used a valve-based cell printer to produce hESCs spheroid ag-
gregates. Starting from dissociated hESCs in the conventional main-
tenance medium, without any additional matrix component, the valve-
based printing process generated printed droplets deposited onto a
plate, which was then flipped for subsequent culture of the cells inside
hanging droplets. This procedure promoted cell-cell adhesion and for-
mation of an individual aggregate within each single droplet. This re-
sulted in spheroids of uniform size. Cell viability was maintained during
and after the printing process. It is unclear if hESCs maintained plur-
ipotency after printing, as this was only assessed by immunostaining
analysis of the pluripotency marker OCT4 and no functional test was
reported. An important feature of this technique is provided by the dual
nozzle setup, allowing to create gradients of cells and other bioinks to
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generate cellular aggregates with variable size. This would allow testing
a number of different aggregate sizes in a faster and more standardized
way than that achievable by manual pipetting. Generation of embryoid
bodies, or spheroids, is often used as a preliminary step in differentia-
tion of hESCs and hiPSCs towards diverse lineages. Homogenous ag-
gregate size and density of cells within individual spheroids in the
culture are important parameters to ensure reproducibility and effi-
ciency during subsequent differentiation. The increased speed of the
technique would also be beneficial in order to reduce cell stress upon
dissociation. An improved procedure, based on the same valve-based
approach and without supporting biomaterial, was then used by the
same group with both hESCs and hiPSCs (Faulkner-Jones et al., 2015).
In this work, the authors assessed the effect of different nozzle lengths
on post-printed viability. Both increased pressure and nozzle length
significantly affected cellular viability, probably due to higher shear
forces applied to the cells during printing, confirming the fragile nature
of hPSCs. Marker analysis, but no functional assay, was used to confirm
maintenance of pluripotency. Reid et al. (2016) used an extrusion
system that was optimized in order to have minimal shear and pressure
related effects on cells. In this case, pluripotency of hiPSCs was tested
post-printing by a functional assay, consisting of formation of embryoid
bodies (EBs) in serum-containing medium and subsequent analysis of
endoderm, mesoderm and ectoderm markers (Reid et al., 2016).
Ability of bioprinted human hiPSCs to differentiate into multiple
lineages was also functionally assessed by Gu et al. (2017), who per-
formed extrusion-based printing of cells within a polysaccharide-based
bioink made of alginate, carboxymethyl-chitosan and agarose. Cross-
linking was performed by immersing scaffolds in calcium chloride after
printing, producing a stable and porous construct in which cells could
proliferate. hiPSCs were then differentiated in situ to self-assembling 3D
EBs that expressed markers of the three germ layers, thus demon-
strating maintenance of pluripotency after printing. In the same work,
hiPSCs within the bioprinted construct were induced to differentiate
along the neural lineage, generating neurons and glial cells (see below).
A possible application of hiPSCs printing and subsequent differ-
entiation is the generation of a 3D construct mimicking a human tissue
for transplantation. In this case, the composition of the bioink is im-
portant not only to ensure long-term hiPSCs viability and maintenance
of 3D structure, but also to form a proper physiological mimetic en-
vironment upon differentiation. As an example, two alternative bioinks
have been tested for post-printing differentiation of cartilage tissue
from hiPSCs: nanofibrillated cellulose (NFC) with alginate (NFC/A) or
Fig. 2. 3D bioprinting and differentia-
tion of hPSCs. Schematic representation
of post-printing differentiation and pre-
printing differentiation strategies. As an
example, neural tissue derived from
human iPSCs is represented. (A) In post-
printing differentiation, hiPSCs are first
printed to generate a 3D construct con-
taining undifferentiated pluripotent
cells. Subsequently, hiPSCs are induced
to differentiate within the construct to
obtain neural cells (e.g. neurons and
astrocytes). In this case there is no con-
trol on the relative position and number
of the cells in the final neural model. (B)
In pre-printing differentiation, hiPSCs
are first induced to differentiate to a
neural lineage with conventional culture
methods. Then hiPSC-derived neural
cells are bioprinted to generate the final
neural model. In this case, the cy-
toarchitecture of the neural model can
be controlled.
Table 1
Human 3D tissues obtained from pluripotent stem cells by post-printing differentiation and pre-printing differentiation.
Lineage Cell source Bioprinting method References
Post-printing differentiation
Plurilineage hiPSCs Extrusion-based Reid et al. (2016)
Plurilineage hiPSCs Extrusion-based Gu et al. (2017)
Neural hiPSCs Extrusion-based Gu et al. (2017)
Cartilage hiPSCs; iChons Extrusion-based Nguyen et al. (2017)
Plurilineage hiPSCs Laser-assisted Koch et al. (2018)
Cardiac hiPSCs Laser-assisted Koch et al. (2018)
Pre-printing differentiation
Liver hESCs; hiPSCs Extrusion-based Faulkner-Jones et al. (2015)
Liver hiPSCs; hASCs; HUVECs DLP Ma et al. (2016)
Liver hiPSCs DLP Yu et al. (2019)
Cardiac hiPSCs DLP Yu et al. (2019)
Cardiac hiPSCs; HUVECs; HCFs Kenzan method Ong et al. (2017a,b)
Vascular hiPSCs Kenzan method Moldovan et al. (2017b)
Cornea hESCs, hASCs Laser-assisted Sorkio et al. (2018)
Plurilineage indicates that the capacity to differentiate into cells of the three germ-layers (ectoderm, endoderm, mesoderm) was tested, after bioprinting, by a
functional assay. hiPSCs: human induced Pluripotent Stem Cells; hESCs: human Embryonic Stem Cells; iChons: mitotically inactivated human chondrocytes; hASCs:
adipose-derived stem cells; HUVECs: human umbilical vein endothelial cell line; HCFs: human adult ventricular cardiac fibroblasts. DLP: digital light processing.
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hyaluronic acid (NFC/HA) (Nguyen et al., 2017). Specifically, pro-
teoglycan and collagen in the cartilage would be simulated by NFC and
alginate, respectively. For effective induction of chondrogenic differ-
entiation, hiPSCs and mitotically inactivated chondrocytes (iChons)
were printed together in NFC/A bioink (proven to be the best bioink in
terms of cell viability) and crosslinked. Printed constructs were main-
tained 7 days in pluripotency medium and then differentiated, giving
rise to hyaline-like cartilaginous tissue after four weeks (Nguyen et al.,
2017). These works suggest that bioinks containing alginate (subse-
quently crosslinked by immersion in calcium chloride) in combination
with either carboxymethyl-chitosan and agarose (Gu et al., 2017) or
NFC (Nguyen et al., 2017) are both suitable for extrusion-based bio-
printing of undifferentiated hiPSCs. It is currently unknown, however, if
hiPSCs printed in NFC/A retain plurilineage differentiation.
The other method used so far for undifferentiated hiPSCs is laser-
assisted bioprinting. A recent paper suggests that hiPSCs are quite
amenable to laser printing itself, but very sensitive to the applied bio-
materials (Koch et al., 2018). Extensive test of biomaterials indicated
that a bioink composed of 85% E8 (a commercial pluripotency medium)
and 15% hyaluronic acid (which allows adjusting the bioink viscosity),
used in combination with Matrigel as substrate coating, make the best
conditions for hiPSCs survival and proliferation after LaBP. Moreover,
Matrigel resulted the best gel substrate for retain the specific printed
pattern over time. Matrigel is a widely used basement membrane pre-
paration extracted from the Engelbreth-Holm-Swarm (EHS) mouse
sarcoma and containing extracellular matrix (ECM) proteins (including
laminin, collagen IV, heparin sulfate proteoglycans, entactin/nidogen)
and growth factors. Its rather undefined composition represents a
possible source of variability and development of more standardized
synthetic matrices would be desirable to overcome this major limita-
tion. Maintenance of pluripotency was tested by spontaneous multi-
lineage differentiation, resulting in no difference between printed and
non-printed cells (in the same bioink). Moreover, directed differentia-
tion showed that laser-printed hiPSCs retain the ability to form beating
cardiomyocytes (Koch et al., 2018).
1.5. Bioprinting differentiated cells derived from hPSCs (pre-printing
differentiation)
Several lineages of potential interest for biomedical applications
have been so far derived from human PSCs and then bioprinted into 3D
constructs. They include liver, cartilage, cornea, cardiac and vascular
tissues (Table 1).
The first attempt to produce PSC-derived bioprinted models of
human liver was reported by Faulkner-Jones et al. (2015), who used the
above-mentioned valve-based dual nozzle setup. hESCs and hiPSCs
were induced to differentiate into hepatocyte-like cells (HLCs) with a
multi-step protocol, which included an endoderm priming phase fol-
lowed by hepatic differentiation and maturation. Differentiating cells
were dissociated during the hepatic differentiation step of the protocol
and printed. After printing, differentiation was allowed to proceed
through the maturation stage before marker analysis. All hepatic mar-
kers were expressed in printed cells at a comparable level with un-
printed control, suggesting that the differentiation process and cell
lineage were not altered by the procedure. In the same work, the au-
thors tested the hypothesis that a 3D environment could promote ma-
turation of hPSC-derived hepatocytes in vitro. They used a hydrogel
containing an alginate solution to print multilayered circular structures.
In this approach, the bioink made of hepatocyte-like cells suspended in
the alginate solution was dispensed by one of the nozzles, while the
other dispensed the crosslinker solution. Despite the resulting tube-like
constructs maintained their structure over time, significant decrease in
viability was reported immediately after printing and for the first 24 h.
Moreover, compared to conventional 2D cultures, a delay in albumin
secretion, used as a readout of hepatic differentiation and maturation,
was observed during subsequent time points.
A more complex model of human liver was described by Ma et al.
(2016), who used a digital light processing (DLP) 3D printing method
based on photopolymerization. Notably, in addition to hiPSC-derived
hepatic progenitors (HPCs), this liver model included umbilical vein
endothelial cells (HUVECs) and human adipose tissue derived stem cells
(hASCs), representing supporting nonparenchymal cells from en-
dothelial and mesenchymal origin. These cells were resuspended in two
different bioinks, specifically: gelatin methacrylate (GelMA), with
stiffness similar to healthy liver tissues, for hiPSC-derived hepatic
progenitors, and a mix of Glycidal methacrylate-hyaluronic acid
(GMHA)/GelMA, known to support vascularization, for the supporting
cells. In DLP, UV light triggers photopolymerization of the hydrogel
solutions. The application of two digital masks (complementary hex-
agonal patterns) in a sequential manner produced a 3D model, in which
HPCs and supporting cells organization resembled an array of liver
lobules with a hexagonal architecture and physiological dimensions.
The designed pattern was generally maintained, but over time HPCs
spontaneously reorganized in aggregates. Liver marker expression
analysis suggested increased maturation of HPCs in the construct. This
observation was also supported by functional analyses using anabolic
(albumin secretion) and catabolic (urea production) readouts (Ma et al.,
2016). Further implementation of this technique could rely on the de-
velopment of improved photocrosslinkable bioinks. To this regard, the
same group recently reported the use of a novel bioink formulation for
DLP-based 3D bioprinting of hiPSC-derived hepatocytes (Yu et al.,
2019). In this case, photocrosslinkable GelMA was mixed with a solu-
tion of decellularized ECM (dECM) from porcine liver, as a first step to
develop a more physiological bioink reproducing the complex bio-
chemical composition of the liver. Such favorable environment is sup-
posed to provide “natural” cues to improve cell phenotype, viability,
function and maturation in the bioprinted construct. dECM-based
photocrosslinkable bioinks can also be used for DLP bioprinting of other
hiPSC-derived cell types of interest. For instance, dECM obtained from
porcine heart left ventricle was used for cardiomyocytes, which were
printed in parallel lines to favor formation of striated myocardial tissue
(Yu et al., 2019). Tuning the light exposure time during printing could
be used to modulate the mechanical properties of heart and liver dECM
bioink formulations, producing environments that recapitulate the pe-
culiar stiffness of normal liver and developing heart. This feature could
promote hiPSC-derived hepatocytes and cardiomyocytes differentiation
and maturation (Mueller and Sandrin, 2010; Young and Engler, 2011;
Yu et al., 2019). More in general, since the stiffness of the biomaterial
can affect stem cell differentiation potential (Engler et al., 2006), the
possibility to tune matrix elasticity could be of interest for modulating
subsequent differentiation of hPSC-derived cells within bioprinted
constructs.
The Kenzan method, which does not require bioink, has also been
recently used to generate 3D constructs from hiPSCs. One example is
represented by hiPSC-derived vascular-like structures (Moldovan et al.,
2017b). Endothelial progenitors (endothelial colony forming cells,
ECFC) and smooth muscle forming cells (SMFC), both derived from
hiPSCs, were first assembled into vascular cell spheroids, which were
then implanted in stainless steel micro-needles. This assembling pro-
moted spheroids fusion in a vascular tissue-like structure, in which cell
translocation and further matrix secretion was observed. The same
biofabrication method was used to generate cardiac tissue (Ong et al.,
2017a,b). In this protocol, spheroids were made of hiPSC-derived car-
diomyocytes mixed with HUVEC endothelial cells and a human cardiac
fibroblast cell line. The bioprinter was set up in order to select only
spheroids of appropriate size before assembling them in the needle
array. The result, upon subsequent removal from the needle array, was
a beating cardiac patch. Notably, 3D bioprinted cardiac patches en-
grafted and showed signs of vascularization upon implantation onto rat
hearts (Ong et al., 2017b).
Human corneal tissues were generated by laser-assisted bioprinting
using limbal epithelial stem cells (LESCs), derived by differentiation of
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hESCs, and hASCs, which are able to differentiate to corneal keratocytes
reproducing corneal stroma (Sorkio et al., 2018). In this work, hESC-
derived LESCs in a laminin-containing bioink were printed alone,
forming a stratified corneal epithelium, or in multiple layers onto
hASCs stromal structures, mimicking the cytoarchitecture of the up-
permost part of the native human cornea.
1.6. Construction of 3D brain models by bioprinting stem cells
In the last years, successful generation of hiPSC-derived self-as-
sembled brain organoids has shown the advantages of 3D neural cul-
tures (Lancaster et al, 2013, 2017; Quadrato et al, 2017; Renner et al,
2017). The 3D environment might potentially favor the formation of
synaptic connectivity and circuits, needed for brain function and dys-
regulated in brain pathologies, such as neuropsychiatric disorders. As
discussed above, self-organization of these structures represents the
major cause of variability between different batches of neural organoids
(Lancaster and Knoblich, 2014). 3D bioprinting is emerging as a pos-
sible alternative strategy to generate neural constructs in a more re-
producible and controlled way. However, due to the complexity of the
nervous system microenvironment, 3D bioprinting of neural tissues
remains a challenging task. In particular, development and optimiza-
tion of proper matrices for 3D neural cultures represents a limiting
critical point (Frampton et al, 2011; Lam et al, 2015). So far, to the best
of our knowledge, only two works have reported 3D bioprinted con-
structs generated from neural cells of human origin (Gu et al., 2016,
2017).
In the first paper (Gu et al., 2016), Gu and colleagues generated a
human 3D neural mini-tissue construct (nMTC) by a microextrusion
printing technology. Human neural progenitors (the commercial Re-
Ncell CX immortalized cell line) were encapsulated in a defined and
well-characterized bioink made of alginate, carboxymethyl-chitosan
and agarose, which was subsequently crosslinked with calcium
chloride. The nMTCs showed a homogeneous cell distribution and
consistent cell viability, promoting cell survival and proliferation. Fol-
lowing the printing process, in situ differentiation was evaluated by
analyzing several neural identity markers. Interestingly, a marked in-
crease of some of them (i.e. the neuronal protein beta-tubulin III, TUJ1;
the Glial Fibrillary Acidic Protein, GFAP; the synaptic vesicles protein
synaptophysin, SYP) was reported in 3D constructs compared to con-
ventional 2D cultures. Finally, spontaneous and bicuculline-induced
calcium analysis demonstrated functional maturation of in situ differ-
entiated neural progenitors.
The same group later reported a successful attempt to print hiPSCs
by using the aforementioned bioink and extrusion-based approach (Gu
et al., 2017). Printed cells were differentiated along the neural lineage
in situ. Marker analysis suggested that, compared with conventional 2D
cultures, neural maturation was enhanced in hiPSC-derived 3D bio-
printed neural constructs. Functional tests were performed 40 days after
printing by evaluating bicuculline-induced calcium flux and cell mi-
gration. Direct comparison of bicuculline-induced activity between
printed and unprinted cells was not reported, leaving unsolved the
question of whether the 3D construct improves also functional prop-
erties in addition to markers expression. Moreover, as suggested by
gene expression analysis, in situ post-printing differentiation generated
a very heterogenous population.
Collectively, these works demonstrate that human neural progeni-
tors can be bioprinted and suggest that bioink formulation is a crucial
point to promote cell survival and spatial distribution inside printed
constructs.
1.7. Future perspectives
Bioprinting allows combining multiple cell types in a defined 3D
architecture, providing the possibility of recapitulating tissue compo-
sition and cytoarchitecture by overcoming lack of reproducible cellular
structure, which is one of the major limitations in the emerging brain
organoid field. This represents an essential requirement for disease
modeling and also for the development of new cell-based therapies.
In conventional hPSC differentiation, mixed populations containing
different lineages are usually obtained. In each experiment, the fraction
of each cell type in the mixed population could be greatly variable,
hampering disease modeling, drug screening and regenerative medicine
applications. For this reason, strategies for the purification of desired
cell types during hPSC differentiation have been set up. These include
fluorescence, or magnetic, sorting and differential adhesion (Amos
et al., 2012). Notably, purification would not be possible in post-
printing differentiation, leaving little control on the composition of the
construct. Moreover, during post-printing differentiation, hiPSCs pro-
liferate and migrate, resulting in the partial or total loss of the original
printed pattern (Koch et al., 2018). Pre-printing differentiation holds
several advantages, including: better control on the cells that will be
Fig. 3. Pre-printing differentiation and
sorting. Schematic representation illus-
trating the possibility to control the cell
composition of the 3D construct by
differentiation of hiPSCs, followed by
sorting of individual cell populations
and bioprinting. Cytoarchitecture and
relative proportions of each cell type
can be controlled. This approach also
allows to include other cell lineages,
e.g. microglia, in the neural construct.
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included in the construct, possibility to combine different cell types
with precise stoichiometry, determining the relative position of each
cell type within the construct (Fig. 3).
We can foresee increasing interest in producing 3D constructs by
pre-printing differentiation of hPSCs. At present, both bioink-based and
scaffold-free approaches have been used. It is likely that no individual
method would be universally suitable for the wide variety of cell types
and tissues that can be derived from hPSCs. Similarly, for the methods
that require a bioink, its composition shall be tuned in order to mimic
the physiological environment of each individual tissue. Optimization
of bioprinting procedures and bioink composition will allow to extend
this technology to challenging cell types, such as hPSC-derived neurons,
to build improved constructs for basic science and applied research.
Despite 3D bioprinting methodologies have been applied only very
recently to hPSCs, existing literature suggests that 3D bioprinted con-
structs may represent significantly improved models of human tissues,
in terms of cytological and functional features (Ma et al., 2016). An
increase of maturation markers was also reported in 3D bioprinted
neural constructs (Gu et al., 2016, 2017). However, it is unclear if this
was mirrored by the acquisition of more mature functional properties.
Moreover, the possibility of bioprinting neurons and neuroglia, besides
neural progenitors, remains unexplored. Extending this approach to the
variety of neuronal and glial cell types that can be derived from hPSCs
would offer new interesting opportunities in the field.
In conclusion, advancement in 3D bioprinting techniques and ma-
terials have opened the possibility to apply these methods to human
pluripotent stem cells, both hESCs and hiPSCs. Compared to the vir-
tually unlimited possibility of generating human tissues offered by
these cells, at present relatively few examples exist of hPSC-derived
bioprinted constructs. This number will conceivably increase in the
near future, possibly including bioprinted human neural tissue models.
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